Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A foray across diagnostic boundaries

Journal of Hepatology

Volumn 44, Issue 2, 2006, Pages 251-252

  Czaja, Albert J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA; URSODEOXYCHOLIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BONE DISEASE; DIAGNOSTIC REASONING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INHIBITION; DRUG MECHANISM; EDITORIAL; HUMAN; LIVER FIBROSIS; MEDICAL DECISION MAKING; NONHUMAN; OVERLAP SYNDROME; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; SYNDROME;

EID: 30344467821     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.037     Document Type: Editorial

References (20)

1. A.J. Czaja The variant forms of autoimmune hepatitis Ann Intern Med 125 1996 588 598
2. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
3. A.J. Czaja, and D.K. Freese Diagnosis and treatment of autoimmune hepatitis Hepatology 36 2002 479 497
4. E.J. Heathcote Management of primary biliary cirrhosis Hepatology 31 2000 1005 1013
5. O Chazouillères, D Wendum, L Serfaty, O Rosmorduc, and R Poupon Long term outcome and response to therapy of primary biliary cirrhosis - autoimmune hepatitis overlap syndrome J Hepatol 44 2006 400 406
6. S. Joshi, K. Cauch-Dudek, I.R. Wanless, K.D. Lindor, R. Jorgenson, and K. Batts Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid Hepatology 35 2002 409 413
7. A.J. Czaja, and H.A. Carpenter Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis J Hepatol 40 2004 644 650
8. A.J. Czaja, and H.A. Carpenter Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis Hepatology 39 2004 1631 1638
9. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J Biol Chem 275 2000 2247 2250
10. F.R. Murphy, R. Issa, X. Zhou, S. Rhatnarajah, H. Nagase, and M.J. Arthur Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis J Biol Chem 277 2002 11069 11076
11. A. Castilla, J. Prieto, and N. Fausto Transforming growth factor β1 and α in chronic liver disease. Effects of interferon alfa therapy N Engl J Med 324 1991 933 940
12. M. Centrella, T.L. McCarthy, and E. Canalis Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone Mol Cell Biol 11 1991 4490 4496
13. W.Y. Almawi, H.N. Beyhum, A.A. Rahme, and M.J. Rieder Regulation of cytokine and cytokine receptor expression by glucocorticoids J Leukoc Biol 60 1996 563 572
14. M. Leuschner, S. Guldutuna, T. You, K. Hubner, S. Bhatti, and U. Leuschner Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis J Hepatol 25 1996 49 57
15. M. Leuschner, K.-P. Maier, J. Schlicting, S. Strahl, G. Herrmann, and H.H. Dahm Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial Gastroenterology 117 1999 918 925
16. J.A. Talwalkar, J.C. Keach, P. Angulo, and K.D. Lindor Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system Am J Gastroenterol 97 2002 1191 1197
17. A.J. Czaja Frequency and nature of the variant syndromes of autoimmune liver disease Hepatology 28 1998 360 365
18. A.J. Czaja, and H.A. Carpenter Autoimmune hepatitis with incidental histologic features of bile duct injury Hepatology 34 2001 659 665
19. A.J. Czaja, H.A. Carpenter, P.J. Santrach, and S.B. Moore Autoimmune cholangitis within the spectrum of autoimmune liver disease Hepatology 31 2000 1231 1238
20. A.J. Czaja, P. Muratori, L. Muratori, H.A. Carpenter, and F.B. Bianchi Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis Liver Int 24 2004 322 329